Dai Z, Si Y, Xiong S, Li Y, Ye J, Gao Q
Cancer Gene Ther. 2025; .
PMID: 40057574
DOI: 10.1038/s41417-025-00884-x.
Rice-Boucher P, Kashentseva E, Dmitriev I, Guo H, Tremblay J, Shoemaker C
bioRxiv. 2025; .
PMID: 39974927
PMC: 11838440.
DOI: 10.1101/2025.01.31.635969.
Liaci A, Chandra N, Vodnala S, Strebl M, Kumar P, Pfenning V
PLoS Pathog. 2025; 21(1):e1012892.
PMID: 39883726
PMC: 11813153.
DOI: 10.1371/journal.ppat.1012892.
Wu E, Robertson A, Zhu H, Stasiak C, Murray-Nerger L, Romanoff E
Viruses. 2025; 16(12.
PMID: 39772136
PMC: 11680334.
DOI: 10.3390/v16121827.
Wienen F, Nilson R, Allmendinger E, Peters S, Barth T, Kochanek S
Mol Ther Oncol. 2025; 32(4):200909.
PMID: 39758252
PMC: 11699628.
DOI: 10.1016/j.omton.2024.200909.
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients.
Raimondi V, Vescovini R, Dessena M, Donofrio G, Storti P, Giuliani N
Front Immunol. 2024; 15:1483806.
PMID: 39539548
PMC: 11557349.
DOI: 10.3389/fimmu.2024.1483806.
Structure-derived insights from blood factors binding to the surfaces of different adenoviruses.
Mudrick H, Lu S, Bhandari J, Barry M, Hemsath J, Andres F
Nat Commun. 2024; 15(1):9768.
PMID: 39528527
PMC: 11555213.
DOI: 10.1038/s41467-024-54049-9.
The αvβ6 integrin specific virotherapy, Ad5-A20.FCU1, selectively delivers potent "in-tumour" chemotherapy to pancreatic ductal adenocarcinoma.
Badder L, Davies J, Meniel V, Maruskova M, Salvador-Barbero B, Bayliss R
Br J Cancer. 2024; 131(10):1694-1706.
PMID: 39369056
PMC: 11555051.
DOI: 10.1038/s41416-024-02869-3.
ADEVO: Proof-of-concept of adenovirus-directed EVOlution by random peptide display on the fiber knob.
Sallard E, Fischer J, Schroeer K, Dawson L, Beaude N, Affes A
Mol Ther Oncol. 2024; 32(4):200867.
PMID: 39346764
PMC: 11439537.
DOI: 10.1016/j.omton.2024.200867.
Broad sialic acid usage amongst species D human adenovirus.
Mundy R, Baker A, Bates E, Cunliffe T, Teijeira-Crespo A, Moses E
Npj Viruses. 2024; 1(1):1.
PMID: 38665237
PMC: 11041768.
DOI: 10.1038/s44298-023-00001-5.
Peak transgene expression after intramuscular immunization of mice with adenovirus 26-based vector vaccines correlates with transgene-specific adaptive immune responses.
Marquez-Martinez S, Salisch N, Serroyen J, Zahn R, Khan S
PLoS One. 2024; 19(4):e0299215.
PMID: 38626093
PMC: 11020485.
DOI: 10.1371/journal.pone.0299215.
New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy.
Chowaniec H, Slubowska A, Mroczek M, Borowczyk M, Braszka M, Dworacki G
Front Immunol. 2024; 15:1375433.
PMID: 38576614
PMC: 10991781.
DOI: 10.3389/fimmu.2024.1375433.
Unravelling molecular dynamics in living cells: Fluorescent protein biosensors for cell biology.
Sanchez C, Ramirez A, Hodgson L
J Microsc. 2024; .
PMID: 38357769
PMC: 11324865.
DOI: 10.1111/jmi.13270.
The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study.
Yi L, Ning Z, Xu L, Shen Y, Zhu X, Yu W
ESMO Open. 2024; 9(2):102239.
PMID: 38325225
PMC: 10937204.
DOI: 10.1016/j.esmoop.2024.102239.
Structural insights into the interaction between adenovirus C5 hexon and human lactoferrin.
Dhillon A, Persson B, Volkov A, Sulzen H, Kadek A, Pompach P
J Virol. 2024; 98(3):e0157623.
PMID: 38323814
PMC: 10949841.
DOI: 10.1128/jvi.01576-23.
Viral platform engineering for targeted gene delivery to human hematopoietic stem cells.
Del Veliz S, Coughlan L
Mol Ther. 2023; 32(1):6-8.
PMID: 38086382
PMC: 10787161.
DOI: 10.1016/j.ymthe.2023.11.025.
Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform.
Yao J, Atasheva S, Wagner N, Di Paolo N, Stewart P, Shayakhmetov D
Mol Ther. 2023; 32(1):103-123.
PMID: 37919899
PMC: 10787117.
DOI: 10.1016/j.ymthe.2023.10.023.
FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment.
Hartmann K, van Gogh M, Freitag P, Kast F, Nagy-Davidescu G, Borsig L
Mol Ther. 2023; 31(10):2914-2928.
PMID: 37641405
PMC: 10556229.
DOI: 10.1016/j.ymthe.2023.08.018.
Fetal gene therapy.
Waddington S, Peranteau W, Rahim A, Boyle A, Kurian M, Gissen P
J Inherit Metab Dis. 2023; 47(1):192-210.
PMID: 37470194
PMC: 10799196.
DOI: 10.1002/jimd.12659.
Could a Non-Cellular Molecular Interactome in the Blood Circulation Influence Pathogens' Infectivity?.
Hardy E, Sarker H, Fernandez-Patron C
Cells. 2023; 12(13).
PMID: 37443732
PMC: 10341357.
DOI: 10.3390/cells12131699.